Cardiomyopathy-linked mutations L29Q and G159D in cardiac troponin C alter the kinetics of Ca(2+)-triggered structural transitions and antagonize PKA phosphorylation signaling.
No takes yet. Share an insight, caveat, or question.
These troponin C mutations may disrupt contractile regulation in cardiomyopathy; hypothesis-generating and should not yet change practice.
Dong et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: